Dividends Calendar Earnings Calendar

DCTH | Delcath Systems, Inc.

Delcath Systems, Inc.

Company profile

  • Industry: Drug Delivery
  • Sector: Healthcare
  • Headquarters:   Queensbury, New York, United States
  • Number of employees::   33
Homepage : delcath.com

Company profile

Delcath Systems, Inc. (NASDAQ-DCTH) is an interventional oncology Company focused on the treatment of primary and metastatic liver cancers. Our investigational product ? HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) ? is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.. MORE

About the Company

Delcath Systems, Inc. Delcath Systems, Inc. is a publicly-traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.

  • Subsidiaries:   Subsidiary: Delcath Systems, Ltd.


1633 Broadway
22nd Floor Suite C
New York, NY 10019
United States

    Key Persons / Board of Directors

    • CEO :  Jennifer Simpson Ph.D. (May 2015–)

    Jump to (Finance sites)

    Their Official Profiles 


    Other stocks 

    t cmg dnow symc kmx wmb hlt vfc arrs amg usg dxc 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 

    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.